Article
[On-line sequential hemodiafiltration (HDF-OL-S): a new therapeutic option].
Servicio de Nefrología, Unidad de Hemodiálisis, Hospital G. U. Gregorio Marañón, Madrid, España.
Nefrologia: publicacion oficial de la Sociedad Espanola Nefrologia (impact factor:
1).
02/2008;
28(4):433-8.
pp.433-8
Source: PubMed
- Citations (14)
-
Cited In (0)
-
Article: On-line haemodiafiltration versus haemodialysis: stable haematocrit with less erythropoietin and improvement of other relevant blood parameters.
[show abstract] [hide abstract]
ABSTRACT: Controlled randomised studies to prove improved cardiovascular stability and improved anaemia management during on-line haemodiafiltration (oHDF) are scarce. 70 patients were treated with both haemodialysis (HD) and oHDF in a cross-over design during 2 x 24 weeks at a dialysis dose of eKt/V> or =1.2. Patients randomised into group A started on HD and switched over to oHDF, whereas patients in group B began with oHDF and were treated with HD afterwards. Intradialytic morbid events (IME), such as symptomatic hypotension or muscle cramps, were noted in case of appearance. Blood parameters reflecting anaemic status, phosphate status, lipid metabolism, oxidative stress, and accumulation of advanced glycation end products were recorded either monthly or at the end of each study phase. The mean incidence of IME was 0.15 IME per treatment, and there was no statistical difference between oHDF and HD. A higher haematocrit (oHDF 31.5% vs. HD 30.5%, p < 0.01) at a lower erythropoietin dose (oHDF 4,913 vs. HD 5,492 IU/week, p = 0.02) was found during oHDF, when the sequence of HD and oHDF had not been taken into account. For the study groups, the results were less distinct: in group A, a higher haematocrit (HD 30.4% vs. oHDF 32.0%, p < 0.01) at a comparable erythropoietin dose (HD 5,421 vs. oHDF 5,187 IU/week, ns) was observed during oHDF, whereas in group B an identical haematocrit (oHDF 30.8% vs. HD 30.7%, ns) was achieved at a reduced erythropoietin dose (oHDF 4,622 vs. HD 5,568 IU/week, p < 0.01). During oHDF, lower levels of free and protein-bound pentosidine and of serum phosphate were found. In contrast to other studies, no benefit regarding cardiovascular stability for oHDF was found, but oHDF could well offer a potential benefit regarding anaemia correction, inflammation, oxidative stress, lipid profiles, and calcium-phosphate product.Blood Purification 01/2006; 24(2):163-73. · 2.10 Impact Factor -
Article: On-line haemodiafiltration. Remarkable removal of {beta}2-microglobulin. Long-term clinical observations
[show abstract] [hide abstract]
ABSTRACT: Background. The accumulation of β 2 ‐microglobulin ( β 2 ‐M) in long‐term dialysis patients may lead to dialysis amyloidosis. In this respect, the removal with different modes of on‐line haemodiafiltration (HDF) of β 2 ‐M was studied. Long‐term clinical observations in patients with more than 10 years of dialysis, treated mainly with biocompatible and highly permeable membranes and in the last years with on‐line HDF are also reported. Methods. In the first part of this report, the reduction ratios and clearances of β 2 ‐M, blood urea nitrogen, creatinine and phosphorus (P) of on‐line HDF with 40 to 120 mI/min replacement fluid are compared with bicarbonate haemodialysis (HD). In the second part, we investigated 16 patients with more than 10 years of dialysis treatment. The prevalence of dialysis amyloidosis and the mean values for serum albumin, serum total cholesterol, HDL and LDL cholesterol and parathyroid hormone are reported, as well as the mean dose of erythropoietin. Results. In the first part with on‐line HDF, starting from HDF 60 ml/min a significantly higher β 2 ‐M reduction ratio and clearance vs HD is noted. In HDF100 (i.e. with 24 l replacement volume per 4‐h treatment) vs HD, a β 2 ‐M reduction ratio of 72.7% vs 49.7% ( P =0.0000) and a β 2 ‐M clearance of 116.8 vs 63.8 ml/min ( P =0.0000) was obtained. Comparing HDFl20 with HDF100, there is a significantly higher β 2 ‐M clearance with the former ( P <0.005), although the β 2 ‐M reduction ratio was not significantly better. In the HDF120 session the amount of β 2 2‐M in the total dialysate was 292 mg per session. If one adds the known 17% adsorption on the polysulfone membrane, a total of 341.6 mg β 2 ‐M per session is removed, which adds up to 1024.8 mg a week. Concerning the small molecules, our results with HDF100 also show a higher creatinine and especially P clearance vs HD. In the second part with 16 patients with more than 10 years of dialysis treatment (mean 14 years 1 month), the mean time on HDF amounted to 39.5% of the total treatment time. In four patients only biocompatible and highly permeable membranes were used, AN69 and mainly polysulfone, and in four other patients these membranes were used for more than 95% of the treatment time. Therefore, it is not surprising that the prevalence of carpal tunnel syndrome was only 12.5% in the patients after 10 years of dialysis. Twenty‐five percent of these patients met the criteria for diagnosis of β 2 ‐M bone‐amyloidosis, proposed by van Ypersele de Strihou et al ., but without a retrospective X‐ray analysis. The mean predialysis β 2 ‐M value was 29.6 mg/l. The mean values for serum albumin, serum total cholesterol, HDL and LDL cholesterol were within normal limits. For the parathyroid hormone a mean of 287.5 pg/ml was found. Subtotal parathyroidectomy was performed in five patients. The mean dose of 43 U erythropoietin/kg per session is comparable with those reported in the literature. Conclusions. Like Canaud, in our renal unit, treatment with on‐line HDF with a highly permeable and biocompatible membrane has proven to be an efficient well‐tolerated and safe technique. Furthermore it leads to a low prevalence of dialysis amyloidosis and a superior P clearance. However, continuous attention must be paid to an on‐line sterile and apyrogenic dialysate. Although on‐line HDF is undoubtedly a more optimal approach of chronic dialytic treatment, it also carries a higher cost, which is currently evaluated to be nearly US$11 per session. -
Article: On-line haemodiafiltration. Safety and efficacy in long-term clinical practice.
Nephrology Dialysis Transplantation 02/2000; 15 Suppl 1:60-7. · 3.40 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
16 adult patients
3 different techniques
70% reduction
clearance rates
greatest clearance
haemoconcentration percentage
hemodiafiltration modes
line haemodiafiltration
lower post-dilution exchange volumes
lower risk
middle molecules
myoglobulin's clearance rates
poor vascular access
pre-dialysis levels
suboptimal access's blood flow
table N1
three techniques
ultrafiltration volumes
useful technique
vascular access's